Selected publications
-
Determinants of earlymortality among 37,568 patientswith colon cancerwho participated in 25 clinical trials from the adjuvant colon cancer endpoints database.
Journal of Clinical Oncology.
2016
Review
GET IT
Times cited: 9 -
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.
Journal of Geriatric Oncology.
2016
Academic Article
GET IT
Times cited: 3 -
Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: Analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database.
Journal of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 37 -
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer.
Journal of the National Cancer Institute.
2014
Academic Article
GET IT
Times cited: 27 -
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial.
Journal of Clinical Oncology.
2011
Academic Article
GET IT
Times cited: 452